Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00612014 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
A Phase 2 study, sponsored by Tranzyme.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
NCT00612014 is a Phase 2 study that has completed, run by Tranzyme. The registered enrollment target is 78 participants.
The verdict
NCT00612014, a Phase 2 study, has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether TZP-101 is effective in the treatment of symptomatic gastroparesis due to diabetes.
Interventions
- DRUG 5% dextrose in water
- DRUG TZP-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00612014
The ClinicalTrials.gov registry entry for NCT00612014 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tranzyme, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5% dextrose in water is the first listed.
NCT00612014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00612014 about?
NCT00612014 is a clinical study titled "Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis". The purpose of this study is to determine whether TZP-101 is effective in the treatment of symptomatic gastroparesis due to diabetes.
What is the current status of trial NCT00612014?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2007-10. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00612014?
The interventions under investigation include: 5% dextrose in water (DRUG), TZP-101 (DRUG).
Who is sponsoring clinical trial NCT00612014?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.